Biogen Deferred Tax Assets and Other Non-Current Assets increased by 3.6% to $777.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 39.1%, from $559.10M to $777.50M. Over 5 years (FY 2020 to FY 2025), Deferred Tax Assets and Other Non-Current Assets shows an upward trend with a 48.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase generally suggests the accumulation of long-term economic benefits or tax recovery potential.
This is the aggregate balance of non-current deferred tax assets and other miscellaneous non-current assets that do not...
Varies widely based on the specific composition of 'other' assets, making it a general indicator of long-term asset health.
deferred_tax_assets_other_noncurrent| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.53B | $2.02B | $208.80M | $1.77B | $1.50B | $1.61B | $280.70M | $1.38B | $1.10B | $754.60M | $293.30M | $697.60M | $681.50M | $631.40M | $560.50M | $559.10M | $637.70M | $729.70M | $750.60M | $777.50M |
| QoQ Change | — | -20.2% | -89.7% | +746.5% | -15.1% | +7.4% | -82.6% | +391.9% | -20.0% | -31.7% | -61.1% | +137.8% | -2.3% | -7.4% | -11.2% | -0.2% | +14.1% | +14.4% | +2.9% | +3.6% |
| YoY Change | — | — | — | — | -40.6% | -20.1% | +34.4% | -21.9% | -26.4% | -53.2% | +4.5% | -49.5% | -38.3% | -16.3% | +91.1% | -19.9% | -6.4% | +15.6% | +33.9% | +39.1% |